Australia's most trusted
source of pharma news
Friday, 29 August 2025
Posted 27 August 2025 PM
Once amongst the world's biggest drugs, these fallen megastars continued to lose revenue in the first half of 2025, but most companies have managed to weather the storm.
US publication PharmaVoice looked at the drugs that have fallen the furthest at the five largest pharmas, and Pharma in Focus investigated how those drugs fared in Australia.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.